Josh Riggs - Net Worth and Insider Trading

Josh Riggs Net Worth

The estimated net worth of Josh Riggs is at least $10,024 dollars as of 2025-07-19. Josh Riggs is the CEO and President of Insight Molecular Diagnostics Inc and owns about 3,505 shares of Insight Molecular Diagnostics Inc (IMDX) stock worth over $10,024. Details can be seen in Josh Riggs's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Josh Riggs has not made any transactions after 2024-04-11 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Josh Riggs

To

Josh Riggs Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Josh Riggs owns 1 companies in total, including Insight Molecular Diagnostics Inc (IMDX) .

Click here to see the complete history of Josh Riggs’s form 4 insider trades.

Insider Ownership Summary of Josh Riggs

Ticker Company Transaction Date Type of Owner
IMDX Insight Molecular Diagnostics Inc 2024-04-11 Interim CEO

Josh Riggs Latest Holdings Summary

Josh Riggs currently owns a total of 1 stock. Josh Riggs owns 3,505 shares of Insight Molecular Diagnostics Inc (IMDX) as of April 11, 2024, with a value of $10,024.

Latest Holdings of Josh Riggs

Ticker Company Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
IMDX Insight Molecular Diagnostics Inc 2024-04-11 3,505 2.86 10,024

Holding Weightings of Josh Riggs


Josh Riggs Form 4 Trading Tracker

According to the SEC Form 4 filings, Josh Riggs has made a total of 1 transactions in Insight Molecular Diagnostics Inc (IMDX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Insight Molecular Diagnostics Inc is the acquisition of 3,390 shares on April 11, 2024, which cost Josh Riggs around $10,001.

Insider Trading History of Josh Riggs

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Josh Riggs Trading Performance

GuruFocus tracks the stock performance after each of Josh Riggs's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Josh Riggs is 6.24%. GuruFocus also compares Josh Riggs's trading performance to market benchmark return within the same time period. The performance of stocks bought by Josh Riggs within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Josh Riggs's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Josh Riggs

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -2.53 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -2.98 LIMIT LIMIT LIMIT LIMIT LIMIT

Josh Riggs Ownership Network

Ownership Network List of Josh Riggs

No Data

Ownership Network Relation of Josh Riggs

Insider Network Chart


Josh Riggs Owned Company Details

What does Insight Molecular Diagnostics Inc do?

Who are the key executives at Insight Molecular Diagnostics Inc?

Josh Riggs is the Interim CEO of Insight Molecular Diagnostics Inc. Other key executives at Insight Molecular Diagnostics Inc include 10 percent owner Broadwood Partners Lp , other: Former Director John Peter Gutfreund , and 10 percent owner Pura Vida Investments, Llc .

Insight Molecular Diagnostics Inc (IMDX) Insider Trades Summary

Over the past 18 months, Josh Riggs made 1 insider transaction in Insight Molecular Diagnostics Inc (IMDX) with a net purchase of 3,390. Other recent insider transactions involving Insight Molecular Diagnostics Inc (IMDX) include a net purchase of 1,188,987 shares made by Patrick W Smith , a net purchase of 8,901,034 shares made by Broadwood Partners Lp , and a net purchase of 151,231 shares made by .

In summary, during the past 3 months, insiders sold 0 shares of Insight Molecular Diagnostics Inc (IMDX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Insight Molecular Diagnostics Inc (IMDX) were sold and 10,291,040 shares were bought by its insiders, resulting in a net purchase of 10,291,040 shares.

Insight Molecular Diagnostics Inc (IMDX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Insight Molecular Diagnostics Inc Insider Transactions

No Available Data

Josh Riggs Mailing Address

Above is the net worth, insider trading, and ownership report for Josh Riggs. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Josh Riggs's mailing address is: Irvine Ca 92618.